CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 44

Industry reads hand-picked by our editors

Sep 24, 2024

Bloomberg
$50 Billion in Sales Make Ozempic and Wegovy Prices Tougher to Justify
The New York Times
Anti-Aging Enthusiasts Are Taking a Pill to Extend Their Lives. Will It Work?
Science
Mpox may trigger large outbreak in one of Africa’s largest cities

Sep 23, 2024

Axios
Johnson & Johnson tries bankruptcy a third time for talc liabilities
The Financial Times
Vaccine alliance battles for funds as donors face financial pressures
STAT
A mysterious anti ‘Big Pharma’ bus is barnstorming swing states

Sep 20, 2024

Nature
Do AI models produce more original ideas than researchers?
Bloomberg
China Cracks Down on Illegal Copies of Novo’s Weight-Loss Drug
The Washington Post
Scientists again link covid pandemic origin to Wuhan market animals

Sep 19, 2024

Financial Times
Schizophrenia: the new drug set to tackle the ‘cancer of psychiatry’
NPR
Sickle cell gene therapies roll out slowly
C&EN
R&D for long COVID is collapsing

Sep 18, 2024

Bloomberg
Novo Says Ozempic ‘Very Likely’ Target for Next US Price Cut
FirstWord Pharma
Coherus’ Udenyca faces short-term supply squeeze
Endpoints News
After I was diagnosed with Merkel cell carcinoma, I discovered how a band of physician-scientists triggered a revolution

Sep 17, 2024

Axios
Why Trump’s drug price positions may clash with GOP’s pharma agenda
FirstWord Pharma
Roche details external, internal manufacturing plans to support obesity pipeline
The Wall Street Journal
The Battle Brewing Over Blood Tests for Cancer

Sep 16, 2024

MedPage Today
Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Says
PMLiVE
Eli Lilly announces FDA approval for Ebglyss in moderate-to-severe atopic dermatitis
Financial Times
Eyecare company Bausch + Lomb explores sale to end messy spin-off

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Survey Report
The Evolution of Outsourced Buffer Production in Manufacturing Custom content for Thermo Fisher Scientific
Playbook
How to Unlock A Successful ICH E6(R3) Implementation Custom content for WCG
Playbook
Successful Biomarker-Driven Cancer Drug Development Custom content for Labcorp

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.